FTC, States Ask Federal Court to Hold ‘Pharma Bro’ Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry

The FTC and seven states have requested a federal court to hold Martin Shkreli in contempt. This legal action follows allegations that Shkreli flagrantly and repeatedly violated a 2022 court order. That specific order imposed a lifetime ban prohibiting him from working within the pharmaceutical industry. The Commission has cited evidence to support these claims, asserting that the Pharma Bro disregarded the legal restrictions placed upon his professional activities in the pharmaceutical sector.